rs10992070
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004560.4(ROR2):c.938-33C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,612,854 control chromosomes in the GnomAD database, including 11,077 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.095 ( 803 hom., cov: 32)
Exomes 𝑓: 0.11 ( 10274 hom. )
Consequence
ROR2
NM_004560.4 intron
NM_004560.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.50
Publications
4 publications found
Genes affected
ROR2 (HGNC:10257): (receptor tyrosine kinase like orphan receptor 2) The protein encoded by this gene is a receptor protein tyrosine kinase and type I transmembrane protein that belongs to the ROR subfamily of cell surface receptors. The protein may be involved in the early formation of the chondrocytes and may be required for cartilage and growth plate development. Mutations in this gene can cause brachydactyly type B, a skeletal disorder characterized by hypoplasia/aplasia of distal phalanges and nails. In addition, mutations in this gene can cause the autosomal recessive form of Robinow syndrome, which is characterized by skeletal dysplasia with generalized limb bone shortening, segmental defects of the spine, brachydactyly, and a dysmorphic facial appearance. [provided by RefSeq, Jul 2008]
ROR2 Gene-Disease associations (from GenCC):
- brachydactyly type B1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal recessive Robinow syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-91731188-G-A is Benign according to our data. Variant chr9-91731188-G-A is described in ClinVar as Benign. ClinVar VariationId is 259432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.128 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ROR2 | ENST00000375708.4 | c.938-33C>T | intron_variant | Intron 6 of 8 | 1 | NM_004560.4 | ENSP00000364860.3 | |||
| ROR2 | ENST00000375715.5 | c.518-33C>T | intron_variant | Intron 6 of 12 | 1 | ENSP00000364867.1 | ||||
| ROR2 | ENST00000550066.5 | n.1406-33C>T | intron_variant | Intron 8 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0954 AC: 14504AN: 152078Hom.: 803 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
14504
AN:
152078
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0866 AC: 21564AN: 248992 AF XY: 0.0873 show subpopulations
GnomAD2 exomes
AF:
AC:
21564
AN:
248992
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.112 AC: 163836AN: 1460658Hom.: 10274 Cov.: 32 AF XY: 0.111 AC XY: 80561AN XY: 726696 show subpopulations
GnomAD4 exome
AF:
AC:
163836
AN:
1460658
Hom.:
Cov.:
32
AF XY:
AC XY:
80561
AN XY:
726696
show subpopulations
African (AFR)
AF:
AC:
1971
AN:
33470
American (AMR)
AF:
AC:
2958
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
2696
AN:
26136
East Asian (EAS)
AF:
AC:
10
AN:
39700
South Asian (SAS)
AF:
AC:
3167
AN:
86204
European-Finnish (FIN)
AF:
AC:
4367
AN:
52622
Middle Eastern (MID)
AF:
AC:
740
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
141714
AN:
1111680
Other (OTH)
AF:
AC:
6213
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
7495
14990
22486
29981
37476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4884
9768
14652
19536
24420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0953 AC: 14510AN: 152196Hom.: 803 Cov.: 32 AF XY: 0.0903 AC XY: 6718AN XY: 74408 show subpopulations
GnomAD4 genome
AF:
AC:
14510
AN:
152196
Hom.:
Cov.:
32
AF XY:
AC XY:
6718
AN XY:
74408
show subpopulations
African (AFR)
AF:
AC:
2612
AN:
41530
American (AMR)
AF:
AC:
1424
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
366
AN:
3472
East Asian (EAS)
AF:
AC:
5
AN:
5192
South Asian (SAS)
AF:
AC:
151
AN:
4824
European-Finnish (FIN)
AF:
AC:
799
AN:
10596
Middle Eastern (MID)
AF:
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8859
AN:
67972
Other (OTH)
AF:
AC:
235
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
661
1323
1984
2646
3307
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
75
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.